Fingerprint
Dive into the research topics of 'Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer
Marc A. Becker, Xiaonan Hou, Piyawan Tienchaianada, Brian B. Haines, Sean C. Harrington, S. John Weroha, Sriram Sathyanarayanan, Paul Haluska
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations